Created at	Source	Raw Value	Validated value
April 27, 2022, 3 a.m.	usa	Safety and reactogenicity profile of fractional and full dose of study vaccines at 28 days post-booster vaccination;Sero-response rate by Spike IgG binding ELISA at 28 days post booster	Safety and reactogenicity profile of fractional and full dose of study vaccines at 28 days post-booster vaccination;Sero-response rate by Spike IgG binding ELISA at 28 days post booster